Literature DB >> 19631764

Can yeast be used to study mitochondrial diseases? Biolistic tRNA mutants for the analysis of mechanisms and suppressors.

Cristina De Luca1, YouFang Zhou, Arianna Montanari, Veronica Morea, Romina Oliva, Celine Besagni, Monique Bolotin-Fukuhara, Laura Frontali, Silvia Francisci.   

Abstract

Base substitutions equivalent to those causing human pathologies have been introduced in yeast mitochondrial tRNA genes. These mutants can be utilized as flexible tools to investigate the molecular aspects of mitochondrial diseases and identify correcting genes. We show that for all studied tRNA mutations (including an homoplasmic one in tRNA(Val)) the severity of phenotypes follows the same trend in four different nuclear backgrounds. Correcting genes include TUF1 and genes encoding aminoacyl-tRNA synthetase. The effect of suppressors was analyzed by Northern blot. Mutated leucyl-tRNA synthetase with highly reduced catalytic activity maintains full suppressing effect, thus suggesting a chaperone-like and/or stabilizing function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631764     DOI: 10.1016/j.mito.2009.07.004

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  13 in total

Review 1.  Emerging therapies for mitochondrial diseases.

Authors:  Michio Hirano; Valentina Emmanuele; Catarina M Quinzii
Journal:  Essays Biochem       Date:  2018-07-20       Impact factor: 8.000

2.  In Vivo Analysis of Mitochondrial Protein Synthesis in Saccharomyces cerevisiae Mitochondrial tRNA Mutants.

Authors:  Arianna Montanari
Journal:  Methods Mol Biol       Date:  2022

3.  The Sua5 protein is essential for normal translational regulation in yeast.

Authors:  Changyi A Lin; Steven R Ellis; Heather L True
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

4.  Structural and functional role of bases 32 and 33 in the anticodon loop of yeast mitochondrial tRNAIle.

Authors:  Arianna Montanari; Cristina De Luca; Patrizio Di Micco; Veronica Morea; Laura Frontali; Silvia Francisci
Journal:  RNA       Date:  2011-09-13       Impact factor: 4.942

Review 5.  The power of yeast to model diseases of the powerhouse of the cell.

Authors:  Matthew G Baile; Steven M Claypool
Journal:  Front Biosci (Landmark Ed)       Date:  2013-01-01

6.  Peptides from aminoacyl-tRNA synthetases can cure the defects due to mutations in mt tRNA genes.

Authors:  Silvia Francisci; Arianna Montanari; Cristina De Luca; Laura Frontali
Journal:  Mitochondrion       Date:  2011-08-31       Impact factor: 4.160

Review 7.  The Mitochondrial Aminoacyl tRNA Synthetases: Genes and Syndromes.

Authors:  Daria Diodato; Daniele Ghezzi; Valeria Tiranti
Journal:  Int J Cell Biol       Date:  2014-02-04

8.  The isolated carboxy-terminal domain of human mitochondrial leucyl-tRNA synthetase rescues the pathological phenotype of mitochondrial tRNA mutations in human cells.

Authors:  Elena Perli; Carla Giordano; Annalinda Pisano; Arianna Montanari; Antonio F Campese; Aurelio Reyes; Daniele Ghezzi; Alessia Nasca; Helen A Tuppen; Maurizia Orlandi; Patrizio Di Micco; Elena Poser; Robert W Taylor; Gianni Colotti; Silvia Francisci; Veronica Morea; Laura Frontali; Massimo Zeviani; Giulia d'Amati
Journal:  EMBO Mol Med       Date:  2014-01-10       Impact factor: 12.137

9.  Short peptides from leucyl-tRNA synthetase rescue disease-causing mitochondrial tRNA point mutations.

Authors:  Elena Perli; Annarita Fiorillo; Carla Giordano; Annalinda Pisano; Arianna Montanari; Paola Grazioli; Antonio F Campese; Patrizio Di Micco; Helen A Tuppen; Ilaria Genovese; Elena Poser; Carmela Preziuso; Robert W Taylor; Veronica Morea; Gianni Colotti; Giulia d'Amati
Journal:  Hum Mol Genet       Date:  2015-12-31       Impact factor: 6.150

10.  Strain-specific nuclear genetic background differentially affects mitochondria-related phenotypes in Saccharomyces cerevisiae.

Authors:  Arianna Montanari; Silvia Francisci; Mario Fazzi D'Orsi; Michele Maria Bianchi
Journal:  Microbiologyopen       Date:  2014-04-02       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.